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We report herein mutations of ATP2C1 in 11
Japanese patients with Hailey±Hailey disease gene
(including ®ve previously reported) and compare the
mutation pattern with clinical phenotypes. Patients
with missense mutations and some of those with
mutations causing premature termination showed
erythema and erosions primarily at intertriginous
areas. In two families with unique mutations, one
with an in-frame three amino acid deletion plus an
eight amino acid insertion and one with a two
base pair deletion predicted to cause premature
truncation, some affected individuals had unique
clinical features ± generalization of Hailey±Hailey
disease and generalized skin eruption resembling
keratotic papules in Darier's disease ± but other
affected individuals did not, suggesting the presence
of severe intrafamilial phenotype variations. Our
®ndings suggest that differences in clinical pheno-
types are probably related to factors other than the
type of causative mutation. Key words: ATP2C1/
Hailey±Hailey disease/mutations/phenotype. J Invest
Dermatol 117:1654±1656, 2001
H
ailey±Hailey disease (HHD; McKusick no. 16960) is
an autosomal dominant inherited skin disease
characterized by recurrent blistering predominantly
at intertriginous areas. Lesions usually appear after
puberty and continue throughout life with only
uncommon long-term remission (Burge, 1992). Occasional patients
have clinical variants such as generalization or lesions of predomi-
nantly verrucous appearance (Burge, 1992; Ikeda et al, submitted).
The gene whose mutations underlie HHD was mapped to the
long arm of chromosome 3 and so far no locus heterogeneity has
been reported (Ikeda et al, 1994; Peluso et al, 1995; Richard et al,
1995). Two independent groups recently identi®ed HHD-causing
mutations in ATP2C1, a homolog of a yeast Ca2+ ATPase that
pumps Ca2+ from the cytosol to the Golgi (Hu et al, 2000; Sudbrak
et al, 2000). In this study, we identi®ed additional mutations of this
gene by conformation sensitive gel electrophoresis (CSGE) analysis
and direct sequencing of genomic DNA from six Japanese families
and solitary patients with HHD. By including our ®ve previously
described Japanese patients with ATP2C1 mutations (Hu et al,
2000), we are able to compare genotype and phenotype in a
reasonably large group of patients of relatively homogeneous
genetic background.
MATERIALS AND METHODS
Diagnosis of the disease was made primarily by clinical features and
medical history. At least one affected individual from each family and all
solitary cases had a biopsy for histologic con®rmation. Autoimmune
blistering diseases such as pemphigus were excluded by immuno¯uor-
escent study. We have analyzed for the mutations in 18 families/patients
with the disease, and detected 11 different mutations in 11 families/
patients. Of the 11 families/patients, eight were sporadic and three were
familial (Table I).
Genomic DNA was prepared from peripheral blood, and CSGE
analysis and polymerase chain reaction (PCR) ampli®cation of exonic
DNA was performed as described previously (Bonifas et al, 1992;
Christiano et al, 1997; Hu et al, 2000). PCR products producing
abnormal CSGE patterns were directly sequenced by the dye-termination
method using an ABI PRISM 310 genetic analyzer. CSGE or restriction
endonuclease analysis was used to exclude the presence of identi®ed
mutations in unaffected individuals in the families and in 50 patients
without HHD.
RESULTS
Mutational analysis We identi®ed mutations in ATP2C1 in 11
out of 18 Japanese HHD (JHHD) patients/families studied
(Table II). Mutations were speci®c to the affected individuals
and were not detected in the unaffected individuals in the families
or in the 50 control subjects without HHD. Mutations were of
quite varied types: four missense, two deletion mutations +
premature termination codon (PTC) formation, one insertion
+ PTC formation, one nonsense, one in-frame deletion, one in-
frame deletion + insertion, and one splice junction mutation. The
skipping of exon 10 in JHHD-6 was con®rmed by reverse
transcription PCR (RT-PCR) and sequencing (data not shown).
Exons in which mutations were observed were 7 (one), 10 (one),
12 (two), 16 (one), 22 (one), 23 (two), and 24 (three) (the number
in brackets indicates the frequency of mutations).
Genotype±phenotype comparison The most interesting case
was JHHD-4. In this family, the affected mother had generalization
of HHD when she was 47 y old (which was precipitated by
pseudomonas aeruginosa infection), and has been showing
complete remission for at least 3 y after becoming 70. She also
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showed erythema and erosions at intertriginous areas from age 47 to
70. Affected ®rst and second sons have shown erythema and
erosions predominantly at axillary and anogenital areas. In this
family, a 2303delAC mutation of the gene leading to PTC at four
amino acids downstream was identi®ed. Another interesting case
was JHHD-7. In this family, the affected father showed generalized
skin eruption resembling keratotic papules, which are usually
observable in Darier's disease patients. On histopathologic
examination of the keratotic papulles, acantholysis at suprabasal
layers and scant corps ronds were observed. After retinoid therapy,
this patient showed erythema that was restricted to the
intertriginous areas. After discontinuation of the treatment,
generalized keratotic papules have recurred so far three times. In
addition, the affected son in JHHD-7 has only faint erythema at the
axillar areas. In this family, a unique mutation of an in-frame three
amino acid deletion plus eight amino acid insertion at exon 12 was
detected in both affected father and son. The case of JHHD-6
shows relatively extensive blisters and erosions at upper back to
nape areas in addition to intertriginous involvement. In this patient,
a GT to GC mutation at the splice donor site of exon 10 was
observed. The remaining cases have shown erythema and erosions
at intertriginous areas. Intrafamilial and interfamilial variations of
response to therapy with topical steroids such as chrobetasol
propionate, however, have been observed (Table I).
DISCUSSION
Spectrum of mutations In this study, we detected six
mutations of ATP2C1 in six additional JHHD patients/families,
and report a total of 11 different mutations including ®ve
previously reported mutations. These ®ndings provide further
support that HHD is caused by the mutations in ATP2C1 that
codes the calcium pump at Golgi, and that there is no genetic
heterogeneity even in different ethnic groups.
Table I. Summary of pro®les of the patients/families
Family/patient Age of onset Involved skin sites Effective therapy Course of disease Unique clinical feature
JHHD-1 male (sporadic) Axilla, groin, perianal Very strong steroid Flare up on occasion None
JHHD-2 female (sporadic) 36 y Axilla, groin, perianal,
submamma
Very strong steroid Flare up on occasion None
JHHD-3 male (sporadic) 29 y Axilla, groin, perianal Very strong steroid Flare up on occasion None
JHHD-4 (familial)
Mother 40 y Axilla, groin, perianal Strongest steroid Remission after age 70 Once generalized by
bacterial infection
First son 24 y Axilla, groin, perianal,
shoulder
Strongest steroid Flare up on occasion None
Second son 26 y Axilla, groin, perianal None Continual None
JHHD-5 female (sporadic) Axilla, groin, perianal Very strong steroid Flare up on occasion None
JHHD-6 male (sporadic) Childhood Groin, lumber, upper back Very strong steroid Flare up on occasion None
JHHD-7 (familial)
Father 53 y General Retinoid Flare up by quitting
therapy
General keratotic papules
+ erythema at
intertriginous areas
Son 35 y Fine erythema at axilla Untreated Continual
JHHD-8 female (sporadic) Axilla, groin, perianal Strongest steroid Flare up on occasion None
JHHD-9 female (sporadic) 52 y Axilla, genital, submamma Retinoid Flare up on occasion Treated by dermablasion
JHHD-10 (familial )
Mother 30 y Axilla, groin, submamma Strongest steroid Flare up on occasion None
Daughter 18 y Fine erythema at axilla, groin Untreated Continual None
JHHD-11 male (sporadic) 42 y Axilla, groin Strongest steroid Flare up on occasion None
Table II. Mutations of ATP2C1 in Japanese families/patients with Hailey±Hailey disease
Family/patient Location Mutation Nucleotide change Consequencea Veri®cation by
JHHD-1b (sporadic) Exon 7 R153X 457
C to T
PTC at codon 153 Dde I
JHHD-2 (sporadic) Exon 12 A304S 910 G to T Missense Bbv I
JHHD-3 (sporadic) Exon 23 P744R 2231 C to G Missense Ava II
JHHD-4 (familial) Exon 24 2303delAC AGACAG ® AGAG Frameshift (PTC + 4aa) CSGE
JHHD-5 (sporadic) Exon 24 2371del TTGT CTTTGTTTGTCT ® CTTTGTCT Frameshift (PTC + 11aa) Tth 111 I
JHHD-6 (sporadic) Intron 10 Splice donor
GT to GC
832+2 T to C Exon skipping (exon 10) CSGE/RT-PCR
JHHD-7 (familial) Exon 12 318±320delLAL CGCTAGCTCTT ® CT ® CCACAATGTGTTGGTGTTATGAGAAT PCR/CSGE
insTMCWCYEN In-frame deletion/insertion
JHHD-8 (sporadic) Exon 16 V463G 1388 T to G Missense CSGE
JHHD-9 (sporadic) Exon 22 2111insA TAGA ® TAAGA Frameshift (PTC + 23aa) CSGE
JHHD-10 (familial) Exon 23 739del I 2215delATT In-frame deletion CSGE
JHHD-11 (sporadic) Exon 24 L749R 2246 T to G Missense CSGE
aPTC + naa indicates a premature termination codon at n amino acids downstream of the mutation.
bMutations JHHD-1 to JHHD-5 were reported previously (Hu et al, 2000). Mutations JHHD-2 and JHHD-3 were incorrectly reported as A304T and P724 previously
(Hu et al, 2000). Mutated exons: 7 (one), 10 (one), 12 (two), 16 (one), 22 (one), 23 (two), 24 (two).
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In previous reports, complete deletion of one ATP2C1 allele was
detected in at least one HHD kindred [HHD-Ma in the reports of
Peluso et al (1995) and Hu et al (2000)], and 19 out of 34 mutations
were of PTC causing mutations, ®ve out of 34 were of exon
skipping mutations, and 10 out of 34 were of missense mutations
(Hu et al, 2000; Sudbrak et al, 2000). In our additional mutation
search on six unrelated patients/families, four out of six mutations
were thought to be ``function-lacking'' mutations (i.e., in-frame
deletion, insertion + PTC, insertion + frameshift PTC, in-frame
deletion + insertion, and splice junction mutation) that alter the
functionally important domains of ATP2C1. One in-frame dele-
tion (739delI) occurred at predicted transmembrane domain 6. One
in-frame deletion/insertion occurred adjacent to a predicted
phosphorylation site. Splice junction mutation of exon 10 was
supposed to result in lack of predicted transmembrane 3 and PTC
formation 22 amino acids downstream of the missing exon 10. The
remaining two were missense mutations that resulted in non-
conservative amino acid substitutions at residues conserved with the
rat pmr1 (Sudbrak et al, 2000). Of these, V463G occurred at around
the predicted hinge domain, and L749R occurred at predicted
transmembrane 6. These ®ndings suggest that the mechanism
underlying the autosomal dominant inheritance in HHD might be
haplo-insuf®ciency. The mutations previously reported and those
detected in this study spread throughout the ATP2C1 gene (i.e.,
exons 2, 3, 7, 8, 10, 11, 12, 13, 15, 16, 17, 18, 20, 21, 22, 23, 24,
26). Mutation hot spots were not observed.
Genotype±phenotype comparison We further compared the
intrafamilial and interfamilial clinical features of the patients in
conjunction with the type of mutations detected in 11 HHD
patients/families. All the patients in whom missense mutations were
detected have been showing common clinical features such as
erythema, erosions, and scales at intertriginous areas, and have not
shown any additional unique features. There were some differences
in the response to topical steroid therapy and secondary infected
pathogens at the affected skin sites, however (Table I).
The remaining three cases/families showed interesting clinical
features and mutation patterns. In the case of JHHD-4, the affected
mother once showed generalization precipitated by pseudomonas
aeruginosa infection when she visited a hot spa at age 47. After that
she showed erythema at intertriginous areas, and she showed
complete remission as she got older. Of note, her occupation was a
housewife. Although we have been observing this family for more
than 19 y, her two affected sons have only shown skin disease at
intertriginous areas. Response to the steroid ointment for each case
in this family is variable, however (i.e., the effect of the strongest
steroid ointment, chrobetasol propionate ointment, has been poor
on the second son) (Table I). In this family, 2303delAC mutation
of the gene leading to PTC at four amino acids downstream was
identi®ed in all affected individuals. In the family JHHD-7, the
affected father showed generalized skin eruption resembling
Darier's disease, and showed minimal erythema at intertriginous
areas after retinoid therapy. After discontinuation of the retinoid
treatment, generalized keratotic papules have recurred so far three
times. This condition has been lasting even after his retirement. His
affected son has been showing only faint erythema at intertriginous
areas. In this family, a unique mutation of in-frame three amino
acid deletion plus eight amino acid insertion at exon 12 was
detected. No speci®c factors to cause generalized keratotic papules
such as other medical conditions, lifestyle, and profession have been
reported. The remaining case of JHHD-6 showed clinical features
from childhood and has been showing relatively extensive blisters
and erosions at upper dorsal to occipital areas in addition to
erythema at intertriginous areas. We cannot conclude that early
onset and extensive blistering are speci®c to this patient, however.
In this patient, GC to GC mutation at the splice donor side of exon
10 was observed.
In conclusion of our mutation and clinical study of Japanese
patients with HHD, we speculate that clinical phenotype might not
relate to the types of mutation in ATP2C1. Clinical phenotype
might simply be in¯uenced by other intrinsic and extrinsic factors
such as expression levels of ATP2C1 in each patient, ultraviolet
irradiation, high environmental temperature, minor mechanical
stimuli in daily life, and the presence of pathogens, etc. To test
these possibilities, we are now evaluating the effect of ultraviolet
irradiation or switching extracellular calcium concentration on the
expression of ATP2C1 in cultured normal human epidermal
keratinocytes by quantitative RT-PCR, and also we are examining
the expression levels of ATP2C1 in multiple different skin sites
from a normal individual. These examinations will provide much
information for the understanding of the intrafamilial and
interfamilial clinical phenotype variation of the patients, as well as
the mechanisms underlying the autosomal dominant inheritance of
this disease.
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